December 15, 2022 Media Coverage from ARCH Venture Partners | Share Gates, Bezos back $75M round led by ARCH for Synchron’s drill-free brain-computer interface implant
December 8, 2022 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Patrick Weiss as Venture Partner
December 5, 2022 Media Coverage from ARCH Venture Partners | Share Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform
November 21, 2022 Media Coverage from ARCH Venture Partners | Share With the clinic in sight, Greg Verdine’s startup bags $178M from ARCH for new class of targeted therapies
November 4, 2022 Media Coverage from ARCH Venture Partners | Share Exclusive: Mt. Everest almost got in the way of a tRNA biotech, but ARCH-backed hC Bioscience climbs to Series A extension
September 12, 2022 Media Coverage from ARCH Venture Partners | Share Freshly baked: ARCH-backed Pretzel Therapeutics takes out the oven mitts to drug diseases in the powerhouse of the cell, Jay Parrish leads company as CEO and Chairman
September 7, 2022 Media Coverage from ARCH Venture Partners | Share In Orbit: New ARCH-backed, Beam-buoyed biotech takes flight, gravitating toward the flash of RNA starlight
August 29, 2022 Media Coverage from ARCH Venture Partners | Share David Baker’s lab and ARCH sprout Lord of the Rings-inspired macrocycle biotech
August 2, 2022 Media Coverage from ARCH Venture Partners | Share BeiGene co-founder and ex-Viela Bio BD leader snag $200M for age-related biotech, with ARCH jumping in
June 29, 2022 Media Coverage from ARCH Venture Partners | Share ARCH Venture Partners raises $3 billion fund to invest in biotech startups despite brutal stock downturn
June 29, 2022 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces $2.975 Billion Fund XII to Create and Fund Early Stage Biotechnology Companies
June 7, 2022 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Promotions and New Appointment
